G&E Herbal Biotechnology Co., Ltd. (TPEX: 4911)

Market Cap	3.36B
Revenue (ttm)	211.15M
Net Income (ttm)	83.82M
Shares Out	59.00M
EPS (ttm)	1.42
PE Ratio	40.12
Forward PE	n/a
Dividend	0.54 (0.94%)
Ex-Dividend Date	Aug 20, 2024

Volume	14,075
Open	57.50
Previous Close	57.10
Day's Range	57.50 - 58.20
52-Week Range	48.58 - 61.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd., a biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. It offers botanical anti-aging cosmetic products, such as facial foam cleanser and cleansing essence, botanical extract toner, lightening lotion, essential oil, and moisturizing serum and cream; SR-100 botanical essence and bromelain illuminating cleansing mousse; and hepato protective agent capsules. The company also provides botanical healthcare products comprising ArthrEnergy...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 37
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4911

Financial Performance

In 2023, G&E Herbal Biotechnology's revenue was 181.44 million, an increase of 180.84% compared to the previous year's 64.61 million. Earnings were 72.40 million, an increase of 880.90%.